Skip to content
Awesome – Lifestyle
Author:
Bridge to Life, Ltd.
/C O R R E C T I O N — Bridge to Life, Ltd./
August 27, 2026
UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System
August 27, 2026
Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond
August 12, 2026
Landmark Study Published in the Journal of the American Medical Association (JAMA) Surgery Validates Bridge to Life’s VitaSmart™ HOPE Perfusion System as a Superior Organ Preservation Technology
May 28, 2026
Groundbreaking Global Study Establishes First International Benchmark Framework for Pediatric Liver Transplantation
May 11, 2026
Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment
May 11, 2026
Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026
April 29, 2026
New Data Demonstrate Safety and Effectiveness of Bridge to Life’s VitaSmart Hypothermic Oxygenated Machine Perfusion (HOPE) System in Partial Graft Pediatric Liver Transplantation
April 29, 2026